Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity? is a research paper published in Immunotherapy Advances (2022). On theSindex it has a DataRank of 0. It has been cited 51 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Sanofi and the Koret Foundation
Grant: NIH 1K08HL161405-01
Sanofi and the Koret Foundation
Grant: NIH R01DK127138
National Institutes of Health
Grant: 1R01DK127138-01
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
National Institutes of Health
Grant: 1K08HL161405-01
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis
FWCI
4.09
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals